Relationship between Sustained Reductions in Plasma Lipid and Lipoprotein Concentrations with Apheresis and Plasma Levels and mRNA Expression of PTX3 and Plasma Levels of hsCRP in Patients with HyperLp(a)lipoproteinemia

Mediators of Inflammation
Claudia StefanuttiJuergen Paal

Abstract

The effect of lipoprotein apheresis (Direct Adsorption of Lipids, DALI) (LA) on plasma levels of pentraxin 3 (PTX3), an inflammatory marker that reflects coronary plaque vulnerability, and expression of PTX3 mRNA was evaluated in patients with hyperLp(a)lipoproteinemia and angiographically defined atherosclerosis/coronary artery disease. Eleven patients, aged 55 ± 9.3 years (mean ± SD), were enrolled in the study. PTX3 soluble protein levels in plasma were unchanged by 2 sessions of LA; however, a downregulation of mRNA expression for PTX3 was observed, starting with the first session of LA (p < 0.001). The observed reduction was progressively increased in the interval between the first and second LA sessions to achieve a maximum decrease by the end of the second session. A statistically significantly greater treatment-effect correlation was observed in patients undergoing weekly treatments, compared with those undergoing treatment every 15 days. A progressive reduction in plasma levels of C-reactive protein was also seen from the first session of LA, with a statistically significant linear correlation for treatment-effect in the change in plasma levels of this established inflammatory marker (R(2) = 0.99; p < 0.001). Our findi...Continue Reading

References

May 15, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Michael S RolphGöran K Hansson
Jul 17, 2004·Acta Cardiologica·Chantal DedobbeleerMarc Renard
Oct 13, 2004·Circulation·Roberto LatiniUNKNOWN Lipid Assessment Trial Italian Network (LATIN) Investigators
Oct 7, 2006·Vascular Pharmacology·Alberto MantovaniRoberto Latini
May 15, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Michael BoehmeRalf Schindler
Nov 19, 2008·Clinical Reviews in Allergy & Immunology·N BassiA Doria
Sep 30, 1930·The Journal of Experimental Medicine·W S Tillett, T Francis
Mar 12, 2011·Clinical and Experimental Immunology·J JylhäväM Hurme
Sep 17, 2011·Cytokine·Claudia StefanuttiDany Belotherkovsky
Dec 20, 2011·Atherosclerosis·Wi-Sun RyuByung-Woo Yoon
May 12, 2012·Mediators of Inflammation·P KunesJ Krejsek
Jan 30, 2013·Atherosclerosis. Supplements·C Stefanutti, U Julius
Feb 28, 2013·Journal of Clinical Immunology·Marijn M SpeeckaertJoris R Delanghe
Mar 13, 2014·Hemodialysis International·Weronika Oleśkowska-FlorekAndrzej Bręborowicz

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
chips
PCR
Enzyme-Linked Immunosorbent Assay
ELISA

Software Mentioned

Biosystems SDS
SPSS
DALI
Applied
LA

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.